Profilo
Tobias Larsson Agervald is Chief Executive Officer at Guard Therapeutics International AB since 2019 and Director at TE Medical Consulting AB since 2018.
Former roles include Senior Medical Director at Astellas Pharma Global Development, Inc. and Associate Professor at Karolinska Institutet.
Education includes doctorates from the University of Uppsala and Harvard Medical School.
Posizioni attive di Tobias Larsson Agervald
| Società | Posizione | Inizio |
|---|---|---|
| GUARD THERAPEUTICS INTERNATIONAL AB | Amministratore Delegato | 15/01/2019 |
TE Medical Consulting AB | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Tobias Larsson Agervald
| Società | Posizione | Fine |
|---|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Tobias Larsson Agervald
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Guard Therapeutics International AB
Guard Therapeutics International AB Pharmaceuticals: MajorHealth Technology Develops medicine for oxidative stress and acute kidney damage | Health Technology |
TE Medical Consulting AB |
















